China CAS:979-02-2 Manufacturer

We've got our personal profits workforce, design and style team, technical group, QC crew and package workforce. We have now strict good quality handle procedures for each process. Also, all of our workers are experienced in printing subject for CAS:979-02-2, High quality, timely service and Aggressive rate, all earn us a excellent fame in xxx field despite the international intense competition.
CAS:979-02-2, now we have 8 years experience of production and 5 years experience in trading with the customers all over the world. our clients mainly distributed in the North America, Africa and Eastern Europe. we can supply high quality items with the very competitive price.

Hot Products

  • Mifepristone

    Mifepristone

    Mifepristone has specifications of CP and IP. DMF and GMP approved.

    CAS:84371-65-3

  • Abiraterone Acetate

    Abiraterone Acetate

    Abiraterone Acetate has CP,USP specifications. DMF, WC available.

    CAS:154229-18-2

  • Testosterone Undecanoate

    Testosterone Undecanoate

    Testosterone undecanoate has CP specification. TP available and DMF under filing.

    CAS:5949-44-0

  • Mifepristone Capsules

    Mifepristone Capsules

    Mifepristone Capsules Specifications:10mg*1
    Indications:Emergency Contraceptive
  • Epiandrosterone

    Epiandrosterone

    Epiandrosterone is a steroid hormone with weak androgenic activity. It is a metabolite of testosterone and dihydrotestosterone (DHT).

    CAS:481-29-8

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept